ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,096Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 939

$957K Total Retail Price of All Prescriptions

Rank: 51 out of 939

590 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 590 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 15,213 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 689 608 1 3
FUROSEMIDE 646 588 2 7
LEVOTHYROXINE SODIUM 619 584 3 4
AMLODIPINE BESYLATE 589 535 4 6
ATORVASTATIN CALCIUM 415 364 5 22
POTASSIUM CHLORIDE 367 347 6 9
HYDROCODONE-ACETAMINOPHEN 361 270 S3 7 1
OMEPRAZOLE 358 313 8 5
WARFARIN SODIUM 317 301 9 17
PRAVASTATIN SODIUM 312 270 10 13
TRAMADOL HCL 305 275 11 16
CITALOPRAM HBR 254 245 12 15
CLOPIDOGREL 240 230 13 28
METFORMIN HCL 238 203 14 8
GABAPENTIN 216 187 15 11
HYDROCHLOROTHIAZIDE 199 172 16 12
METOPROLOL TARTRATE 194 180 17 10
PREDNISONE 192 170 18 42
LOSARTAN POTASSIUM 180 173 19 29
SERTRALINE HCL 173 164 20 24
METOPROLOL SUCCINATE 159 132 21 21
PLAVIX 158 146 22 48
CYMBALTA 155 134 23 44
CARVEDILOL 153 144 24 25
SIMVASTATIN 150 138 25 2
ISOSORBIDE MONONITRATE ER 150 147 25 53
MELOXICAM 149 138 27 14
CRESTOR 147 123 28 34
PANTOPRAZOLE SODIUM 145 138 29 66
NEXIUM 139 106 30 18
DONEPEZIL HCL 136 136 31 30
DIGOXIN 133 126 32 45
ATENOLOL 130 111 33 19
ESCITALOPRAM OXALATE 129 111 34 61
LIPITOR 119 110 35 127
TAMSULOSIN HCL 119 102 35 27
DIOVAN 119 109 35 50
ISOSORBIDE MONONITRATE 118 118 38 274
MEGESTROL ACETATE 117 110 R 39 136
CARBIDOPA-LEVODOPA 107 107 40 102
COMBIVENT 106 96 41 120
RANITIDINE HCL 102 102 42 35
ZOLPIDEM TARTRATE 101 80 43 20
METFORMIN HCL ER 99 93 44 76
TRAZODONE HCL 97 78 45 26
CLONIDINE HCL 93 78 46 39
LYRICA 91 73 47 63
TRIAMTERENE-HCTZ 87 87 48 33
GLIPIZIDE ER 83 83 49 88
ALENDRONATE SODIUM 82 78 50 40
NAMENDA 80 79 51 49
LANTUS 80 74 51 59
FLUTICASONE PROPIONATE 79 63 53 43
GLIPIZIDE 79 76 53 52
LEVOCETIRIZINE DIHYDROCHLORIDE 78 64 55 278
BYSTOLIC 78 72 55 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 72 57 64
DILTIAZEM 24HR CD 75 53 58 126
QUINAPRIL HCL 73 72 59 133
DILTIAZEM ER 72 67 60 94
AMIODARONE HCL 71 71 61 160
VENLAFAXINE HCL ER 71 68 61 121
AZITHROMYCIN 70 57 63 32
RANEXA 70 69 63 248
FENTANYL 68 39 S2 65 104
POLYETHYLENE GLYCOL 3350 68 67 65 57
DIVALPROEX SODIUM 66 64 67 95
TERAZOSIN HCL 65 65 68 114
AMOX TR-POTASSIUM CLAVULANATE 65 58 68 144
TRILIPIX 63 59 70 231
JANUVIA 63 56 70 110
ZETIA 63 42 70 103
PRIMIDONE 62 62 73 228
RISPERIDONE 62 57 73 82
DEXILANT 62 60 73 212
LEVOFLOXACIN 59 54 76 86
RAMIPRIL 58 52 77 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 77 23
NYSTOP 58 58 77 289
AMLODIPINE BESYLATE-BENAZEPRIL 56 44 80 58
CELEBREX 55 49 81 106
CIPROFLOXACIN HCL 54 52 82 54
CARAFATE 53 52 83 209
SINGULAIR 52 41 84 101
ALLOPURINOL 50 39 85 31
LEXAPRO 50 37 85 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.